» Articles » PMID: 34520248

Prevalence of Hirsutism Among Reproductive-Aged African American Women

Overview
Date 2021 Sep 14
PMID 34520248
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Hirsutism is the most common clinical symptom of hyperandrogenism, but racial and ethnic-specific thresholds have not been established. Our objective was to characterize hirsutism using self-report of hair growth in a large sample of African American women. The Study of Environment, Lifestyle, and Fibroids is a prospective community-based cohort study of African American women (23-34 at recruitment). A total of 1568 participants received the modified Ferriman-Gallwey (mFG) pictorial assessment and were asked if they were ever bothered by excess hair. We estimated the prevalence of hirsutism (mFG score ≥8) and associations of acne, polycystic ovary syndrome (PCOS), and menstrual cycle characteristics with hirsutism. We also explored hirsutism defined by the 95th percentile of scores in our cohort (mFG = 11) and a newly recommended criterion, mFG = 4. We could determine hirsutism status in 1556 women. Thirty-seven percent reported being bothered by excess hair, and 10% met the mFG criterion for hirsutism. History of severe facial acne was positively associated with hirsutism (prevalence ratio: 1.90; 95% confidence interval [CI]: 1.30-2.76), as was physician-diagnosed PCOS (2.22, 95% CI: 1.30-3.81). Women with irregular menstrual cycles were also more likely to report hirsutism (1.78, 95% CI: 1.00-3.18). Results were similar using mFG ≥11 and attenuated using mFG ≥4. Hirsutism prevalence was 10% in this community sample of African American women and was associated with PCOS, severe acne, and irregular menstrual cycles suggesting this represented hirsutism caused by hyperandrogenism. Ethnically diverse, population-based studies assessing the association between mFG score and androgen levels are needed to better understand the hirsutism threshold as a clinical marker of hyperandrogenism.

Citing Articles

Comparison of self-assessed and clinician-assessed hirsutism diagnosed according to the modified Ferriman-Gallwey scale among female outpatients in Brazil.

Oliveira T, Oliveira T, Santana D, Rocha A, Candido A, Comim F Arch Endocrinol Metab. 2024; 68:e230271.

PMID: 39420908 PMC: 11213573. DOI: 10.20945/2359-4292-2023-0271.


Physician Level Assessment of Hirsute Women and of Their Eligibility for Laser Treatment With Deep Learning.

Thomsen K, Jalaboi R, Winther O, Lomholt H, Lorentzen H, Hogsberg T Lasers Surg Med. 2024; 57(1):80-87.

PMID: 39308029 PMC: 11776445. DOI: 10.1002/lsm.23843.


Prevalence of and Risk Factors Associated with Polycystic Ovary Syndrome Among Female University Students of Health Sciences in a Middle Eastern Country.

Alkhezi F, AlNemash N, AlMutairi J, Saleh S, Almutairi M, Saleh S Womens Health Rep (New Rochelle). 2024; 5(1):579-587.

PMID: 39206018 PMC: 11347869. DOI: 10.1089/whr.2023.0176.


Statins for women with polycystic ovary syndrome not actively trying to conceive.

Xiong T, Fraison E, Kolibianaki E, Costello M, Venetis C, Kostova E Cochrane Database Syst Rev. 2023; 7:CD008565.

PMID: 37462232 PMC: 10353291. DOI: 10.1002/14651858.CD008565.pub3.


Comparison of image-based modified Ferriman-Gallway score evaluation with in-person evaluation: an alternative method for hirsutism diagnosis.

Oliveira T, Oliveira T, Rocha A, Reis F, Candido A, Premaor M Arch Dermatol Res. 2022; 315(6):1783-1787.

PMID: 36508021 DOI: 10.1007/s00403-022-02495-0.


References
1.
Karrer-Voegeli S, Rey F, Reymond M, Meuwly J, Gaillard R, Gomez F . Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism. Medicine (Baltimore). 2009; 88(1):32-45. DOI: 10.1097/md.0b013e3181946a2c. View

2.
Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale H, Futterweit W . The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2008; 91(2):456-88. DOI: 10.1016/j.fertnstert.2008.06.035. View

3.
Mimoto M, Oyler J, Davis A . Evaluation and Treatment of Hirsutism in Premenopausal Women. JAMA. 2018; 319(15):1613-1614. PMC: 6025746. DOI: 10.1001/jama.2018.2611. View

4.
Ferriman D, GALLWEY J . Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961; 21:1440-7. DOI: 10.1210/jcem-21-11-1440. View

5.
Ladson G, Dodson W, Sweet S, Archibong A, Kunselman A, Demers L . Racial influence on the polycystic ovary syndrome phenotype: a black and white case-control study. Fertil Steril. 2011; 96(1):224-229.e2. PMC: 3132396. DOI: 10.1016/j.fertnstert.2011.05.002. View